How does using escitalopram or other SSRIs in late pregnancy affect the risk of persistent pulmonary hypertension in the newborn?

Epidemiological data suggest that SSRIs, including escitalopram, particularly in late pregnancy, may increase persistent pulmonary hypertension risk in newborns to approximately 5 cases per 1,000 pregnancies, compared with 1–2 per 1,000 in the general population.